InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
2
T+90 hit rate
60%
T+90 mean return
+12.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by RIEDEL NORBERT G, Director. Officer active across 6 companies, notably Eton Pharmaceuticals, Inc.. Cumulatively, 24 filings have been published. Breakdown: 2 buys · 2 sells. Total volume traded: €721k. Activity tracked since 17 May 2021. The latest transaction was disclosed on 21 April 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations24 total
12,500 shares@ US$7.310.0094% mcap20.5% of flowCommon StockSEC:0001437749-26-013041:0
12,500 shares@ US$7.310.0089% mcap20.5% of flowCommon StockSEC:0001437749-26-013041
30,000 shares@ US$4.4229.5% of flowCommon StockSEC:0001437749-26-003230
30,000 shares@ US$4.420.014% mcap29.5% of flowCommon StockSEC:0001437749-26-003230:0
27,400 shares@ US$3.5820.1% of flowCommon StockSEC:0001437749-25-000466:0
3,731 shares0Ordinary SharesSEC:0001765581-24-000077:0
46,092 sharesCommon StockSEC:0000950170-24-090806:0
10,461 sharesCommon StockSEC:0000950170-24-070725:0
3,075 shares0Ordinary SharesSEC:0001765581-23-000088:0
3,282 sharesCommon StockSEC:0000899243-23-015179:0
8,000 shares@ US$55.2856.9% of flowOrdinary SharesSEC:0001765581-22-000096:0
14,270 sharesCommon StockSEC:0000899243-22-001199
14,270 sharesCommon StockSEC:0000899243-22-001199:0
100,000 shares@ US$2.2350.0% of flowCommon StockSEC:0001415889-21-005779:0
Ideal exit: 2 Sept 2022 (T+270)
100,000 shares@ US$2.23100.0% of flowCommon StockSEC:0001415889-21-005779
Ideal exit: 2 Sept 2022 (T+270)
1,306 shares@ US$147.960.0011% mcap50.0% of flowOrdinary SharesSEC:0001765581-21-000108:0
1,306 shares@ US$147.9621.5% of flowOrdinary SharesSEC:0001765581-21-000108
2,246 shares0Ordinary SharesSEC:0001765581-21-000081:0
2,246 shares0Ordinary SharesSEC:0001765581-21-000081
380,000 shares0Common StockSEC:0001415889-21-002619
380,000 shares0Common StockSEC:0001415889-21-002619:0
380,000 shares0Common StockSEC:0001415889-21-002573
380,000 shares0Common StockSEC:0001415889-21-002573:0
12,500 sharesCommon StockSEC:0001127602-16-039325:0
24 of 24 declarations
About RIEDEL NORBERT G
Norbert G. Riedel is a director at Eton Pharmaceuticals, Inc.
